Ignite Creation Date:
2024-05-06 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 2:28 PM
Study NCT ID:
NCT05291039
Status:
COMPLETED
Last Update Posted:
2024-03-28
First Post:
2022-03-12
Brief Title:
Infliximab and Adalimumab in Inflammatory Bowel Disease Patients
Sponsor:
Rehab Werida
Organization:
Damanhour University
Organization Data
Organization:
Damanhour University
Class:
OTHER
Study ID:
Infliximab Adalimumab in IBD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rehab Werida
Lead Sponsor Class:
OTHER
Responsible Party:
Rehab Werida
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Damanhour University
Old Name:
None
Old Organization:
None